1939
DOI: 10.1172/jci101099
|View full text |Cite
|
Sign up to set email alerts
|

The Coagulation Defect in Hemophilia: Studies of the Clot Promoting Activity Associated With Plasma Euglobulin in Hemophilia 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
12
0

Year Published

1942
1942
2013
2013

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 27 publications
(13 citation statements)
references
References 4 publications
1
12
0
Order By: Relevance
“…Those samples of plasma exposed to the other three surfaces for the same length of time had markedly prolonged coagulation times. It has recently been reported that there exists in cell-free citrated normal human plasma a factor, independent of prothrombin and fibrinogen (8,9), capable of reducing the coagulation time of hemophilic blood in vivo and in vitro. The effect of foreign surfaces on this plasma factor was studied.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Those samples of plasma exposed to the other three surfaces for the same length of time had markedly prolonged coagulation times. It has recently been reported that there exists in cell-free citrated normal human plasma a factor, independent of prothrombin and fibrinogen (8,9), capable of reducing the coagulation time of hemophilic blood in vivo and in vitro. The effect of foreign surfaces on this plasma factor was studied.…”
Section: Methodsmentioning
confidence: 99%
“…The clot-promoting activity for hemophilic blood is associated with the euglobulin fraction of cellfree plasma (8,9). This fraction has been called in publications from this laboratory "globulin substance" and by Howell (10) "plasma thromboplastin."…”
Section: Methodsmentioning
confidence: 99%
“…Although its activity is not quite so high as that of some thromboplastins of animal origin, it has the great advantage of containing only human material, and therefore introduces no heterologous protein when added to human plasma protein fractions." 14 (40,41) for the fractions which shorten the clotting time of hemophilic blood suggest that the active component is not so labile as prothrombin.…”
Section: Fibrinogen and Fibrinmentioning
confidence: 99%
“…Furthermore, it was shown that such activity was associated with the plasma euglobulin of normal plasma (2) and was deficient in hemophilic blood (3). The preceding paper (4) has shown that this antihemophilic activity is largely present in Fractions I and III-2, obtained in the separation of the various globulin fractions of the plasma proteins.…”
mentioning
confidence: 96%